Previous 10 | Next 10 |
2023-08-10 09:04:53 ET Stereotaxis press release ( NYSE: STXS ): Q2 GAAP EPS of -$0.07 beats by $0.01 . Revenue of $7.86M (+27.8% Y/Y) beats by $1.18M . Outlook: Stereotaxis reiterates its expectation of double-digit revenue growth in 2023 driven by revenue...
ST. LOUIS, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the second quarter ended June 30, 2023. “Stereotaxis delivered 28% revenu...
2023-08-09 14:08:30 ET Stereotaxis ( NYSE: STXS ) is scheduled to announce Q2 earnings results on Thursday, August 10th, before market open. The consensus EPS Estimate is -$0.07 (flat Y/Y) and the consensus Revenue Estimate is $6.68M (+8.6% Y/Y).Over the last 1 year, STXS ...
ST. LOUIS, July 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients have been successfully treated utilizing Abbott’s EnSite ™ X EP System...
ST. LOUIS, July 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2023 second quarter on Thursday, August 10, 2023 before the ...
2023-06-16 14:00:02 ET Gainers: Evelo Biosciences ( EVLO ) +120% . Sientra ( SIEN ) +29% . TMC the metals company ( TMC ) +24% . ICZOOM Group ( IZM ) +20% . iRobot Corporation ( IRBT ) +20% . Marker Therapeutics ( MRKR ) ...
2023-06-16 10:08:10 ET Gainers: Oncorus ( ONCR ) +264% . Microbot Medical ( MBOT ) +24% . NeuBase Therapeutics ( NBSE ) +19% . Community Health Systems ( CYH ) +8% . Homology Medicines ( FIXX ) +4% . Losers: Panbela Therap...
ST. LOUIS, June 15, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it intends to initiate a first-in-human trial to support the CE Mark submission for its MAGiC™ cath...
ST. LOUIS, May 25, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in Craig-Hallum’s 20th Annual Institutional In...
ST. LOUIS, May 23, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in robotic technologies for the treatment of cardiac arrhythmias, today announced the first treatment of patients with a newly launched Genesis Robotic Magnetic Navigation (RMN) system at Advocate Christ Medic...
News, Short Squeeze, Breakout and More Instantly...
The Dow Jones index closed higher by around 0.5% on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around ...
ST. LOUIS, May 29, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announces the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Gene...
ST. LOUIS, May 24, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received CE Mark recertification under the European Union’s new Medical Device Regulation...